BR112012001271A2 - método para a previsão de ganho de peso associado com uma terapia farmacêutica - Google Patents
método para a previsão de ganho de peso associado com uma terapia farmacêuticaInfo
- Publication number
- BR112012001271A2 BR112012001271A2 BR112012001271A BR112012001271A BR112012001271A2 BR 112012001271 A2 BR112012001271 A2 BR 112012001271A2 BR 112012001271 A BR112012001271 A BR 112012001271A BR 112012001271 A BR112012001271 A BR 112012001271A BR 112012001271 A2 BR112012001271 A2 BR 112012001271A2
- Authority
- BR
- Brazil
- Prior art keywords
- weight gain
- gain associated
- pharmaceutical therapy
- predicting weight
- predicting
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N23/00—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00
- G01N23/20—Investigating or analysing materials by the use of wave or particle radiation, e.g. X-rays or neutrons, not covered by groups G01N3/00 – G01N17/00, G01N21/00 or G01N22/00 by using diffraction of the radiation by the materials, e.g. for investigating crystal structure; by using scattering of the radiation by the materials, e.g. for investigating non-crystalline materials; by using reflection of the radiation by the materials
- G01N23/207—Diffractometry using detectors, e.g. using a probe in a central position and one or more displaceable detectors in circumferential positions
- G01N23/2076—Diffractometry using detectors, e.g. using a probe in a central position and one or more displaceable detectors in circumferential positions for spectrometry, i.e. using an analysing crystal, e.g. for measuring X-ray fluorescence spectrum of a sample with wavelength-dispersion, i.e. WDXFS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- Dispersion Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27150809P | 2009-07-22 | 2009-07-22 | |
| PCT/US2010/042208 WO2011011267A1 (en) | 2009-07-22 | 2010-07-16 | Method for predicting weight gain associated with a pharmaceutical therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012001271A2 true BR112012001271A2 (pt) | 2016-02-10 |
Family
ID=42663617
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012001271A BR112012001271A2 (pt) | 2009-07-22 | 2010-07-16 | método para a previsão de ganho de peso associado com uma terapia farmacêutica |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20120108947A1 (pt) |
| EP (1) | EP2457098B1 (pt) |
| JP (1) | JP5650734B2 (pt) |
| KR (3) | KR20140040290A (pt) |
| CN (2) | CN104749333A (pt) |
| AU (1) | AU2010274140B2 (pt) |
| BR (1) | BR112012001271A2 (pt) |
| CA (1) | CA2765617A1 (pt) |
| EA (1) | EA201270188A1 (pt) |
| ES (1) | ES2517268T3 (pt) |
| MX (1) | MX2012000952A (pt) |
| WO (1) | WO2011011267A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20140114676A1 (en) * | 2012-10-23 | 2014-04-24 | Theranos, Inc. | Drug Monitoring and Regulation Systems and Methods |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4933844A (en) | 1988-09-26 | 1990-06-12 | Otvos James D | Measurement of blood lipoprotein constituents by analysis of data acquired from an NMR spectrometer |
| AU2384292A (en) | 1991-07-30 | 1993-03-02 | North Carolina State University | Method and apparatus for measuring blood lipoprotein levels by nmr spectroscopy |
| KR100620257B1 (ko) * | 1998-11-30 | 2006-09-13 | 노보 노르디스크 에이/에스 | 의료 시스템 및 의학적 자가 치료를 위해 환자에 의해사용되는 시스템의 제어 방법 |
| NZ519403A (en) * | 2001-06-21 | 2005-03-24 | Pfizer Prod Inc | Use of insulin in a medicament to reduce weight gain in a diabetic patient who is using exogenous insulin to control blood sugar levels |
| WO2003012416A1 (en) | 2001-08-01 | 2003-02-13 | Liposcience, Inc. | Method of determining presence and concentration of lipoprotein x in blood plasma and serum |
| GB0213786D0 (en) * | 2002-06-14 | 2002-07-24 | Imp College Innovations Ltd | Metabolic phenotyping |
| US7243030B2 (en) | 2002-10-25 | 2007-07-10 | Liposcience, Inc. | Methods, systems and computer programs for deconvolving the spectral contribution of chemical constituents with overlapping signals |
| AU2003286726A1 (en) * | 2002-10-25 | 2004-05-13 | Metabolon, Inc. | Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| EP1735631A2 (en) | 2004-04-01 | 2006-12-27 | Liposcience, Inc. | Nmr clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples |
| US8518021B2 (en) * | 2004-05-27 | 2013-08-27 | Baxter International Inc. | Apparatus and method for therapeutic delivery of medication |
| WO2007050318A2 (en) * | 2005-10-24 | 2007-05-03 | Duke University | Lipidomics approaches for central nervous system disorders |
| ATE530916T1 (de) * | 2007-12-19 | 2011-11-15 | Lilly Co Eli | Verfahren zur vorhersage des ansprechens auf eine pharmazeutische therapie der fettsucht |
| CN101468976B (zh) * | 2007-12-27 | 2013-11-20 | 百时美施贵宝公司 | Sglt2抑制剂的晶体结构及其制备方法 |
-
2010
- 2010-07-16 US US13/382,532 patent/US20120108947A1/en not_active Abandoned
- 2010-07-16 CN CN201510115022.7A patent/CN104749333A/zh active Pending
- 2010-07-16 KR KR1020147006852A patent/KR20140040290A/ko not_active Application Discontinuation
- 2010-07-16 EA EA201270188A patent/EA201270188A1/ru unknown
- 2010-07-16 KR KR1020167014413A patent/KR20160067197A/ko not_active Application Discontinuation
- 2010-07-16 MX MX2012000952A patent/MX2012000952A/es active IP Right Grant
- 2010-07-16 CN CN201080032654.2A patent/CN102472758B/zh not_active Expired - Fee Related
- 2010-07-16 KR KR1020127001749A patent/KR20120044984A/ko not_active Application Discontinuation
- 2010-07-16 BR BR112012001271A patent/BR112012001271A2/pt not_active IP Right Cessation
- 2010-07-16 WO PCT/US2010/042208 patent/WO2011011267A1/en active Application Filing
- 2010-07-16 ES ES10737701.2T patent/ES2517268T3/es active Active
- 2010-07-16 CA CA2765617A patent/CA2765617A1/en not_active Abandoned
- 2010-07-16 AU AU2010274140A patent/AU2010274140B2/en active Active
- 2010-07-16 JP JP2012521689A patent/JP5650734B2/ja active Active
- 2010-07-16 EP EP10737701.2A patent/EP2457098B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX2012000952A (es) | 2012-02-28 |
| CN102472758A (zh) | 2012-05-23 |
| AU2010274140A1 (en) | 2012-01-19 |
| CN104749333A (zh) | 2015-07-01 |
| KR20120044984A (ko) | 2012-05-08 |
| WO2011011267A1 (en) | 2011-01-27 |
| JP5650734B2 (ja) | 2015-01-07 |
| CA2765617A1 (en) | 2011-01-27 |
| KR20160067197A (ko) | 2016-06-13 |
| JP2012533754A (ja) | 2012-12-27 |
| CN102472758B (zh) | 2015-05-06 |
| EP2457098B1 (en) | 2014-08-13 |
| US20120108947A1 (en) | 2012-05-03 |
| ES2517268T3 (es) | 2014-11-03 |
| KR20140040290A (ko) | 2014-04-02 |
| EP2457098A1 (en) | 2012-05-30 |
| EA201270188A1 (ru) | 2012-06-29 |
| AU2010274140B2 (en) | 2013-09-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1011764A2 (pt) | composição farmacêutica, e, método para preparar uma composição farmacêutica | |
| BR112012025967A2 (pt) | armação de leito para um leito articulado e método para fabricar um leito articulado com uma armação de suporte reforçada | |
| BR112012002102A2 (pt) | composição farmaceutica e metodo para preparar uma composição farmaceutica | |
| BR112012005210A2 (pt) | composição polimerizável e sistema para cobertura de uma superfície de unha | |
| BRPI1008598A2 (pt) | composição farmacêutica para inalação | |
| BRPI0822518A2 (pt) | Método e disposição para a fabricação de uma estrutura laminada | |
| BR112013018900A2 (pt) | conjuntos para uma estrutura | |
| BR112014015042A2 (pt) | composição farmacêutica, e, método para obter uma composição radiofarmacêutica | |
| BR112012029866A2 (pt) | método para a determinação da presença de uma proteína steap-1 | |
| FI20105414A0 (fi) | Menetelmä ja sovitelma rakenteen liikkumisen estämiseksi | |
| BR112014000035A2 (pt) | unidade de verificação e método para a calibragem de uma unidade de verificação | |
| BR112012004034A2 (pt) | disposição de conexão para uma disposição de sensor e disposição de sensor | |
| BRPI0812040A2 (pt) | Indicações para terapia de anti-il-i-beta | |
| BR112013008074A2 (pt) | combinações farmacêuticas | |
| BR112013014993A2 (pt) | método para produção de aço elétrico com grão orientado | |
| BR112012010615A2 (pt) | estrutura de colméia e método para formar uma estrutura de colméia | |
| BR112013014588A2 (pt) | composição de amidoamina, e, método para formar uma composição de amidoamina | |
| BR112012003154A2 (pt) | descanso para uma motocicleta | |
| BRPI1010642A2 (pt) | tecnologias de plataforma para doenças ocorrendo espontaneamente | |
| BR112013013415A2 (pt) | composição farmacêutica, e, método para a preparação de uma composição | |
| ES1072052Y (es) | Plataforma de elevacion para revision de aerogeneradores | |
| FI20116069L (fi) | Rullatyönnin ja rullan pultti rullatyönnintä varten | |
| BR112013011716A2 (pt) | distribuidor reforçado para lança de pós-combustão | |
| BR112012001271A2 (pt) | método para a previsão de ganho de peso associado com uma terapia farmacêutica | |
| BR112013000898A2 (pt) | disposição para uma trava |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2471 DE 15-05-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |